| Market Cap | ₹1,141.33 CrSmall Cap |
|---|---|
| P/E TTM | 5.93Sector 37.77 |
| RSI | 29.25Oversold Zone |
| Deal value | ₹1,000 Cr |
| Share of market cap | 87.6% |
Key highlights
- Fundraise of up to ₹1,000 crore approved through Qualified Institutions Placement
- Proposed raise constitutes 87.6% of the company's ₹1,141.33 crore market capitalization
- Capital to be raised via equity shares or convertible securities in one or more tranches
- Fundraise is subject to shareholder approval through a special resolution
- Proceeds expected to support FY30 revenue target of ₹20,000 crore and FMCG expansion
A ₹1,000 Crore Capital Infusion Strategy
Elitecon International's Board has greenlit a substantial fundraising plan involving the issuance of equity shares or convertible securities through Qualified Institutions Placements. The aggregate amount is capped at ₹1,000 crore, which is a significant figure compared to the company's current market capitalization of ₹1,141.33 crore. This capital raise, which may be executed in one or more tranches, is subject to the approval of shareholders via a special resolution.
The Board or a designated committee will finalize the pricing and terms based on prevailing market conditions and regulatory frameworks at the time of the issuance.
Scaling Up: From Millions to Billions
- July 2025: Board previously proposed raising ₹300 crore via QIP of equity shares
- June 2025: Evaluated raising ₹75 crore through preferential allotment or FCCBs
- November 2024: Completed a preferential issue of 2.27 crore shares for ₹22.79 crore
- September 2026: Signed a USD 60 million export framework with World Class 77 South Africa
- June 2026: Reported a contracted tobacco export order book exceeding USD 119 million
Backing The FY30 Growth Ambitions
The proposed fundraise aligns with the company’s long-term strategy to scale operations across international markets. In June 2026, management reaffirmed an ambitious target of achieving ₹20,000 crore in annual revenue by FY30. This growth roadmap includes a planned ₹700 crore investment focused on FMCG expansion.
The current QIP approval provides the necessary financial headroom to execute these capital-intensive projects and manage the working capital requirements of an expanding international order book, which currently features significant contracts in the Middle East and Africa.
Financial Performance and Market Context
This capital injection follows a period of rapid revenue growth tempered by bottom-line pressure. For the quarter ended March 31, 2026, Elitecon reported operating revenue of ₹1,880.69 crore, a 500.5% year-on-year increase. However, the company recorded a net loss of ₹85.05 crore for the same period, with operating profit margins declining to -4.0%.
On the bourses, the stock is currently trading in oversold territory with an RSI of 29.25. The company maintains a strong FII holding of 36.43% and a promoter holding of 59.43% as of the latest reporting period.
| Date | Announcement | Amount |
|---|---|---|
| 07 Oct 2026 | Board meeting to consider fundraising via equity shares, QIP, preferential issue, rights issue, or debt securitiesSource: livemint.com | – |
| 18 Jul 2025 | Proposal to raise capital through a Qualified Institutions Placement (QIP) of equity sharesSource: BSE filing | ₹300.00 Cr |
| 25 Jun 2025 | Proposal to consider raising funds via preferential allotment, convertible warrants, FCCBs, or QIPSource: news9live.com | ₹75.00 Cr |
| 09 Jan 2025 | Board meeting to evaluate fundraising options via rights issue, preferential allotment, or private placementSource: BSE filing | – |
| 22 Nov 2024 | Preferential issue of up to 2,27,90,000 equity shares of Rs 10 each on a private placement basisSource: zerodha.com | ₹22.79 Cr |
What to watch next
- Shareholder approval of the QIP proposal via special resolution
- Determination of the floor price and issuance date for the first QIP tranche
- Updates on the execution of the USD 60 million South African supply agreement
- Next quarterly financial results announcement scheduled for late 2026
| Share price | ₹7.14 |
|---|---|
| Market capitalisation | ₹1,141.33 Cr |
| Revenue (annual) | ₹5,074.80 Cr |
| Net profit (annual) | ₹161.98 Cr |
| Revenue (latest quarter) | ₹1,880.69 Cr+8.01% vs previous quarter |
| Net profit (latest quarter) | -₹85.05 Cr-182.12% vs previous quarter |
| P/E (TTM) | 5.93×Sector 37.77× |
| Promoter holding | 59.43%0.00% QoQ |
| FII holding | 36.43%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Elitecon International Limited announcing the board approval for raising up to ₹1,000 crore through QIP. Market figures from a third-party data provider.
Track Elitecon International live
Get the next Elitecon International filing on Telegram seconds after it lands. 15 days free.
